165 related articles for article (PubMed ID: 23504554)
1. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L
Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
[TBL] [Abstract][Full Text] [Related]
2. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
4. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
[TBL] [Abstract][Full Text] [Related]
5. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
[TBL] [Abstract][Full Text] [Related]
6. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm.
Li L; Sima X; Bai P; Zhang L; Sun H; Liang W; Liu J; Zhang L; Gao L
Clin Dev Immunol; 2012; 2012():567586. PubMed ID: 22844323
[TBL] [Abstract][Full Text] [Related]
7. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
[TBL] [Abstract][Full Text] [Related]
8. Interactions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis.
Jia F; Sun R; Li J; Li Q; Chen G; Fu W
Genet Test Mol Biomarkers; 2016 Jul; 20(7):398-401. PubMed ID: 27227383
[TBL] [Abstract][Full Text] [Related]
9. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
[TBL] [Abstract][Full Text] [Related]
10. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
[TBL] [Abstract][Full Text] [Related]
11. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
[TBL] [Abstract][Full Text] [Related]
12. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
[TBL] [Abstract][Full Text] [Related]
15. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.
Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C
Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183
[TBL] [Abstract][Full Text] [Related]
16. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
Bulibu J; Wang W; Tang Y; Li N; Saifuding K
Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777
[TBL] [Abstract][Full Text] [Related]
17. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M
Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
[TBL] [Abstract][Full Text] [Related]
18. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.
Gao LB; Li LJ; Pan XM; Li ZH; Liang WB; Bai P; Zhu YH; Zhang L
Biol Chem; 2013 Mar; 394(3):415-20. PubMed ID: 23183747
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S
Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
[TBL] [Abstract][Full Text] [Related]
20. Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma.
Li J; Liu X; Qiao Y; Qi R; Liu S; Guo J; Gui Y; Li J; Yu H
Front Oncol; 2018; 8():413. PubMed ID: 30319976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]